Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $120
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong maintains an Equal-Weight rating on Zimmer Biomet Holdings (NYSE:ZBH) and lowers the price target from $140 to $120.
November 08, 2023 | 9:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Zimmer Biomet Holdings and lowered the price target from $140 to $120.
The lowering of the price target by Morgan Stanley indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100